NVDA vs QMCO

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.

QMCO exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9, indicating severe weakness across nearly all fundamental health metrics. The company suffers from a negative Price-to-Book ratio (-0.56), signaling negative shareholder equity, and a precarious liquidity position with a Current Ratio of 0.51. Despite modest revenue growth of 8.6%, the company is deeply unprofitable with a -37.76% profit margin and a catastrophic 5-year price decline of 95.3%. The combination of massive earnings misses and insolvency indicators suggests a high risk of bankruptcy or significant restructuring.